VIMWEYGA
Live / Applied — First extension granted (statement of use) (as of 07 Nov 2025)
What this means for you
Not registered yet, but its 16 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98502284
- Mark type
- Stylized text
- Filed
- 16 Apr 2024
- Published for opposition
- 25 Mar 2025
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of complement-medicated diseases and disorders
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 08 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Nov 2025 — SOU EXTENSION 1 GRANTED
- 07 Nov 2025 — SOU EXTENSION 1 FILED
- 07 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Mar 2025 — PUBLISHED FOR OPPOSITION
- 19 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Mar 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 03 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Feb 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Nov 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 27 Nov 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED